RxDoctor Payments Data

Kristina Unseld, APRN

Psychiatric/Mental Health · Lincoln, NENPI 1245071257

Payments from drug & device makers

$1,264in general payments, 2019–2025

Across 78 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$356
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$281
  • Otsuka America Pharmaceutical, Inc.$203
  • Neurocrine Biosciences, Inc.$74
  • Johnson & Johnson$44
  • Axsome Therapeutics, Inc.$43
  • plus $263 from 12 others

What the payments were for

  • Food & beverage$1,264100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,264 in reported general payments places this provider in the 55th percentile of 255 psychiatric/mental health providers in Nebraska.

See all psychiatric/mental health providers in Nebraska

Medicare billing

Part B allowed, 2024
$7,477
Medicare patients
65
Services billed
81

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Quetiapine Fumarate18$198
Buspirone Hcl16$194
Zolpidem Tartrate11$125
Alprazolam12$94
Risperidone12$48

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →